WO2001000189A3 - Combinaison d'inhibiteurs de mtp et principes actifs agissant sur le metabolisme et leur utilisation dans les medicaments - Google Patents

Combinaison d'inhibiteurs de mtp et principes actifs agissant sur le metabolisme et leur utilisation dans les medicaments Download PDF

Info

Publication number
WO2001000189A3
WO2001000189A3 PCT/EP2000/005575 EP0005575W WO0100189A3 WO 2001000189 A3 WO2001000189 A3 WO 2001000189A3 EP 0005575 W EP0005575 W EP 0005575W WO 0100189 A3 WO0100189 A3 WO 0100189A3
Authority
WO
WIPO (PCT)
Prior art keywords
combination
metabolism
influence
active agents
medicaments
Prior art date
Application number
PCT/EP2000/005575
Other languages
German (de)
English (en)
Other versions
WO2001000189A2 (fr
Inventor
Rudi Gruetzmann
Ulrich Mueller
Original Assignee
Bayer Ag
Rudi Gruetzmann
Ulrich Mueller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Rudi Gruetzmann, Ulrich Mueller filed Critical Bayer Ag
Priority to AU56829/00A priority Critical patent/AU5682900A/en
Publication of WO2001000189A2 publication Critical patent/WO2001000189A2/fr
Publication of WO2001000189A3 publication Critical patent/WO2001000189A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne l'utilisation d'une combinaison contenant au moins un inhibiteur de MTP (composante A) sélectionné et des principes actifs agissant sur le métabolisme (composante B) destiné à lutter contre des maladies. L'invention concerne également des médicaments contenant cette combinaison et leur production.
PCT/EP2000/005575 1999-06-25 2000-06-16 Combinaison d'inhibiteurs de mtp et principes actifs agissant sur le metabolisme et leur utilisation dans les medicaments WO2001000189A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU56829/00A AU5682900A (en) 1999-06-25 2000-06-16 Combination of mtp inhibitors and active agents that influence the metabolism and use thereof in medicaments

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19929012.1 1999-06-25
DE19929012A DE19929012A1 (de) 1999-06-25 1999-06-25 Kombination von MTP-Inhibitoren und stoffwechselbeeinflussenden Wirkstoffen und ihre Verwendung in Arzneimitteln

Publications (2)

Publication Number Publication Date
WO2001000189A2 WO2001000189A2 (fr) 2001-01-04
WO2001000189A3 true WO2001000189A3 (fr) 2001-08-02

Family

ID=7912418

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/005575 WO2001000189A2 (fr) 1999-06-25 2000-06-16 Combinaison d'inhibiteurs de mtp et principes actifs agissant sur le metabolisme et leur utilisation dans les medicaments

Country Status (3)

Country Link
AU (1) AU5682900A (fr)
DE (1) DE19929012A1 (fr)
WO (1) WO2001000189A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ531890A (en) * 2002-02-28 2006-02-24 Japan Tobacco Inc Ester compound and medicinal use thereof
JPWO2003101983A1 (ja) * 2002-05-31 2005-09-29 アステラス製薬株式会社 テトラヒドロピラン誘導体
EP1669345A4 (fr) 2003-08-29 2008-02-20 Japan Tobacco Inc Derive d'ester et utilisation medicale de celui-ci
US8101774B2 (en) 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
CA2654183A1 (fr) * 2006-06-02 2007-12-13 San Diego State University Research Foundation Compositions et procedes pour ameliorer l'hyperlipidemie

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023593A1 (fr) * 1996-11-27 1998-06-04 Pfizer Inc. AMIDES INHIBANT LA SECRETION D'Apo B ET/OU LA PROTEINE MTP
WO1998050028A1 (fr) * 1997-05-01 1998-11-12 Bristol-Myers Squibb Company Combinaisons therapeutiques d'inhibiteur de mtp et de vitamine liposoluble destinees a reduire les taux de lipides seriques

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023593A1 (fr) * 1996-11-27 1998-06-04 Pfizer Inc. AMIDES INHIBANT LA SECRETION D'Apo B ET/OU LA PROTEINE MTP
WO1998050028A1 (fr) * 1997-05-01 1998-11-12 Bristol-Myers Squibb Company Combinaisons therapeutiques d'inhibiteur de mtp et de vitamine liposoluble destinees a reduire les taux de lipides seriques

Also Published As

Publication number Publication date
DE19929012A1 (de) 2000-12-28
WO2001000189A2 (fr) 2001-01-04
AU5682900A (en) 2001-01-31

Similar Documents

Publication Publication Date Title
EP1378240A3 (fr) Compositions pharmaceutiques à base d'arsenic pour le traitement du myelome multiple
BG106075A (en) Use of cyp2d6 inhibitors in combination therapies
EP1140840A4 (fr) Diphenylurees a substituants -g(v)-carboxyaryles, inhibitrices de kinase raf
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
WO1999005096A3 (fr) Inhibiteurs d'urokinase
HUP0102281A3 (en) Prodrugs of dipeptidyl peptidase iv inhibitors, pharmaceutical compositions comprising thereof and their use
EP2261200A3 (fr) Formes modifiée d'agents à activitée pharmacologique et leurs usages
HUP0102250A3 (en) Compounds of unstable dipeptidyl peptidase iv inhibitors, pharmaceutical compositions comprising thereof and their use
WO2003042246A3 (fr) Traitement medical
SI1509232T1 (sl) Kombinacija antagonista nmda in zaviralcev acetilholinesteraze za zdravljenje alzheimerjeve bolezni
DE60134349D1 (de) Synergistische Kombinationen enthaltend einen Renininhibitor für Kardiovaskulären Erkrankungen
HK1059213A1 (en) Treatment of type 2 diabetes with inhibitors of dipetidyl peptidase iv
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
MXPA02006826A (es) Un inhibidor de division celular y un metodo de produccion del mismo.
EP1419785A4 (fr) Medicaments contenant un inhibiteur de la chymase et un inhibiteur de l'ace comme principes actifs
YU63699A (sh) Preparati za tretiranje i prevenciju arterijske tromboze i korišćenje inhibitora faktora xa samog ili u kombinaciji sa plateletnim antiagregacionim agensom
WO2002034201A3 (fr) Utilisation d'inhibiteurs de l'apoptose des pericytes pour le traitement et/ou la prevention de la retinopathie diabetique
WO2002003978A3 (fr) Combinaison d'inhibiteurs de fbpase et d'agents antidiabetiques utile pour le traitement du diabete
EP1099442A3 (fr) Méthodes d'administration d'inhibiteurs de apo B-sécrétion/MTP
WO2001056555A3 (fr) Utilisation d'inhibiteurs de cox-2 dans le traitement de la constipation
WO2002040016A8 (fr) Association d'inhibiteurs de calpaïne et de piegeurs des formes reactives de l'oxygene
MXPA03001455A (es) Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
EP0870502A3 (fr) Utilisation d'inhibiteurs de l'assimilation d'adénosine pour la fabrication d'un médicament pour le traitement de la pancréatite
GB9907571D0 (en) Compounds
WO2001000189A3 (fr) Combinaison d'inhibiteurs de mtp et principes actifs agissant sur le metabolisme et leur utilisation dans les medicaments

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP